Top

Huisarts en wetenschap

Gepubliceerd in:

01-07-2005 | Beschouwing

Nieuwe topicale immunomodulatoren voor de behandeling van atopisch eczeem

Auteur: Esther van Zuuren

Gepubliceerd in: Huisarts en wetenschap | Uitgave 7/2005

semenvatting

1. Er is een nieuwe behandeling voor atopisch eczeem, namelijk tacrolimus en pimecrolimus.

2. Tacrolimus 0,1% is net zo effectief als een klasse-II-corticosteroïd, tacrolimus 0,03% is effectiever dan een klasse-I-corticosteroïd en pimecrolimus is minder effectief dan een klasse-II-corticosteroïd.

vorige artikel Overwegingen van huisartsen bij het interpreteren van uitslagen van laboratoriumonderzoek

volgende artikel Tussen geneeskunde en geneeskunst

Sillevis Smitt JH. Constitutioneel eczeem; de mogelijkheden van lokale therapie. Ned Tijdschr Geneeskd 2002;146:400-3.PubMed

Van Zuuren EJ. Tacrolimus (Protopic®) geregistreerd. Gebu 2002;36:84.

http://www.emea.eu.int/humandocs/Humans/EPAR/protopic/protopic.htm.

Van Zuuren EJ. Pimecrolimus (Elidel®) geregistreerd. Gebu 2003;37:92.

IB-tekst Elidel® via www.cbg-meb.nl, geneesmiddeleninformatiebank.

Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002;46:228-41.CrossRefPubMed

Reitamo S. Tacrolimus: A new topical immunomodulatory therapy for atopic dermatitis. J Allergy Clin Immunol 2001;107:445-8.CrossRefPubMed

Bornhövd E, Burgdorf WHC, Wollenberg A. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases. J Am Acad Dermatol 2001;45:736-43.CrossRefPubMed

Marsland AM, Griffiths CEM. The macrolide immunosuppressants in dermatology: mechanisms of actions. Eur J Dermatol 2002;12:618-21.PubMed

Bekersky I, Fitzsimmons W, Tanase A, Maher RM, Hodosh E, Lawrence I. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J Am Acad Dermatol 2001;44:S17-27.CrossRefPubMed

Eichenfield LF, Lucky AW, Boguniewicz M, Langley RGB, Cherill R, Marshall, et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis. J Am Acad Dermatol 2002;46:495-504.CrossRefPubMed

Eichenfield LF, Beck LB. Elidel (pimecrolimus) cream 1%: a nonsteroidal topical agent for the treatment of atopic dermatitis. J Allergy Clin Immunol 2003;111:1153-68.PubMed

Hanifin JM, Ling MR, Langley R, Breneman D, Rafal E. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, Efficacy. J Am Acad Dermatol 2001;44:S28-38.CrossRefPubMed

Paller A, Eichenfeld LF, Leung DYM, Stewart D, Appell M. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001;44:S47-57.CrossRefPubMed

Reitamo S, Rustin M, Ruzicka T, Cambazard F, Kalimo K, Friedmann PS, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortison butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002;109:547-55.CrossRefPubMed

Reitamo S, Van Leent EJ, Ho V, Harper J, Ruzicka T, Kalimo K, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002;109:539-46.CrossRefPubMed

Reitamo S, Harper J, Bos JD, Cambazard F, Bruijnzeel-Koomen C, Van der Valk P, et al. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than hydrocortison acetate in children with moderate to severe atopic dermatitis:results of a randomized double-blind controlled trial. Br J Dermatol 2004;150:554-62.CrossRefPubMed

Drake L, Prendergast M, Maher R, Breneman D, Korman N, Satoi Y, et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001;44:S65-72.CrossRefPubMed

Wellington K, Jarvis B. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis. Drugs 2002;65:817-40.CrossRef

Wahn U, Bos JD, Goodfield M, Caputo R, Kapp K, Manjra A, et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 2002;110:1-8.CrossRef

Kapp A, Kapp K, Bingham A, Fölster-Holst R, Ortonne JP, Potter PC, et al. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a non-steroid anti-inflammatory drug. J Allergy Clin Immunol 2002;110:277-84.CrossRefPubMed

Meurer M, Fölster-Holst R, Wozel G, Weidinger G, Jünger M, Braütigam M. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology 2002;205:271-7.CrossRefPubMed

Whalley D, Huels J, McKenna SP, Van Assche D. The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parent’s quality of life in the treatment of pediatric atopic dermatitis. Pediatrics 2002;110:1133-6.CrossRefPubMed

Soter NA, Fleischer AB, Webster GF, Monroe E, Lawrence I. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, Safety. J Am Acad Dermatol 2001;44:S39-46.CrossRefPubMed

Fleischer AB, Ling M, Eichenfield L, Satoi Y, Jaracz E, Rico MJ, et al. Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. J Am Acad Dermatol 2002;47:562-70.CrossRefPubMed

Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001;44:S58-64.CrossRefPubMed

Reitamo S, Wollenberg A, Schöpf E, Perrot JL, Marks R, Ruzicka T, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 2000;136:999-1006.CrossRefPubMed

Paller A, Caro I, Weinstein G, Rico MJ and the Tacrolimus Ointment Study Group. Long-term safety and efficacy of tacrolimus ointment in atopic dermatitis patients: open-label study. Ann Dermatol Venereol 2002;129:1S247.

http://www.fda.gov/cder/drug/infopage/protopic/default.htm

Williams H. New treatments for atopic dermatitis. BMJ 2002;324:1533-4.CrossRefPubMed

Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005;330:516.CrossRefPubMed

Eichenfield LF. Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy 2004;59:86-92.CrossRefPubMed

Titel: Nieuwe topicale immunomodulatoren voor de behandeling van atopisch eczeem
Auteur: Esther van Zuuren
Publicatiedatum: 01-07-2005
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Huisarts en wetenschap / Uitgave 7/2005
Print ISSN: 0018-7070
Elektronisch ISSN: 1876-5912
DOI: https://doi.org/10.1007/BF03084336

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

semenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 7/2005

Ongezondheidsrecht

Verslavingszorg en allochtonen

Glazen plafond? Vrouwelijk charmeoffensief doet mannen tekort

In je hok!

Huisarts en Wetenschap, jaargang 2005, nummer 7 Continuïteit werkt

Intellectuele veelvraat